Stay updated on Ixazomib Combo in Relapsed/Refractory MM Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page.

Latest updates to the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe study record history now displays that recruitment has closed and adds a new version tag, Revision: v3.6.0, while removing the previous Revision: v3.5.5.SummaryDifference0.4%

- Check17 days agoChange DetectedStudy Record Versions now show 'Results Submitted' with Revision: v3.5.5, replacing 'No Results Posted' and Revision: v3.5.4. This situates the study within the record's results-availability timeline and documents the latest revision in the history.SummaryDifference0.2%

- Check39 days agoChange DetectedA new page revision entry v3.5.4 has been added, and the previous entry v3.5.3 has been removed, updating the page's displayed version in the footer.SummaryDifference0.1%

- Check60 days agoChange DetectedThis update only changes the site’s displayed revision/version indicator from v3.5.0 to v3.5.3, with no indication of changes to the clinical trial’s history or study details.SummaryDifference0.1%

- Check96 days agoChange DetectedA new revision entry, v3.5.0, was added to the history and revision v3.4.3 was removed.SummaryDifference0.1%

- Check110 days agoChange DetectedAdded Oversight and Study Status entries on 2026-03-05 and updated the record to Revision v3.4.3; the previous revision v3.4.2 (2025-09-09) was removed.SummaryDifference0.6%

Stay in the know with updates to Ixazomib Combo in Relapsed/Refractory MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Combo in Relapsed/Refractory MM Clinical Trial page.